Consideration on the relation between the removal efficiency of levetiracetam and the clinical presentation by the difference in the dialysis treatment conditions
Not Applicable
- Conditions
- Epilepsy
- Registration Number
- JPRN-UMIN000042042
- Lead Sponsor
- Social medical corporation Kawashimakai Kawashima Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
The present dialysis treatment condition is a patient besides Pre-dilution On-line HDF A sleeping pill and a Antipsychotic taking medication regularly The patient who can't get consent in study participation The patient who judged that a doctor was improper in study participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REBECHIRASETAMU blood level From change in dialysis method, 4 weeks later
- Secondary Outcome Measures
Name Time Method Drowsiness by VAS and the score of the appetite From change in dialysis method, 4 weeks later